EE04316B1 - Asolotriasiinid ja -pürimidiinid, neid sisaldavadfarmatseutilised kompositsioonid ning nende kasutamine ravimite valmistamiseks - Google Patents
Asolotriasiinid ja -pürimidiinid, neid sisaldavadfarmatseutilised kompositsioonid ning nende kasutamine ravimite valmistamiseksInfo
- Publication number
- EE04316B1 EE04316B1 EEP199900019A EE9900019A EE04316B1 EE 04316 B1 EE04316 B1 EE 04316B1 EE P199900019 A EEP199900019 A EE P199900019A EE 9900019 A EE9900019 A EE 9900019A EE 04316 B1 EE04316 B1 EE 04316B1
- Authority
- EE
- Estonia
- Prior art keywords
- azolotriazines
- pyrimidines
- medicaments
- manufacture
- pharmaceutical compositions
- Prior art date
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2329096P | 1996-07-24 | 1996-07-24 | |
| US68604796A | 1996-07-24 | 1996-07-24 | |
| US08/899,242 US6124289A (en) | 1996-07-24 | 1997-07-23 | Azolo triazines and pyrimidines |
| PCT/US1997/013072 WO1998003510A1 (en) | 1996-07-24 | 1997-07-23 | AZOLO TRIAZINES AND PYRIMIDINES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE9900019A EE9900019A (et) | 1999-08-16 |
| EE04316B1 true EE04316B1 (et) | 2004-06-15 |
Family
ID=27362048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP199900019A EE04316B1 (et) | 1996-07-24 | 1997-07-23 | Asolotriasiinid ja -pürimidiinid, neid sisaldavadfarmatseutilised kompositsioonid ning nende kasutamine ravimite valmistamiseks |
Country Status (15)
| Country | Link |
|---|---|
| JP (2) | JP4704521B2 (pl) |
| CN (3) | CN1104432C (pl) |
| AR (1) | AR049583A2 (pl) |
| BR (1) | BR9710544A (pl) |
| CA (1) | CA2259583C (pl) |
| CZ (1) | CZ299451B6 (pl) |
| EA (1) | EA004403B1 (pl) |
| EE (1) | EE04316B1 (pl) |
| HR (1) | HRP970413A2 (pl) |
| IL (4) | IL127871A0 (pl) |
| NO (1) | NO315610B1 (pl) |
| NZ (1) | NZ333777A (pl) |
| PL (1) | PL195762B1 (pl) |
| SI (1) | SI9720045B (pl) |
| SK (1) | SK286461B6 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1368094T3 (da) * | 2001-03-13 | 2007-07-02 | Bristol Myers Squibb Pharma Co | 4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)-pyrazolo[1,5-a]-1,3,5-triazin, dens enantiomerer og farmaceutisk acceptable salte som corticotropin-frigivende faktor-receptor- ligander |
| WO2004110454A1 (ja) * | 2003-06-13 | 2004-12-23 | Ishihara Sangyo Kaisha, Ltd. | アデノシンＡ2ａ受容体アゴニストの投与が必要な疾患を治療又は予防するための組成物 |
| US7329662B2 (en) * | 2003-10-03 | 2008-02-12 | Hoffmann-La Roche Inc. | Pyrazolo-pyridine |
| GB0519957D0 (en) * | 2005-09-30 | 2005-11-09 | Sb Pharmco Inc | Chemical compound |
| KR101088239B1 (ko) * | 2006-09-20 | 2011-11-30 | 일라이 릴리 앤드 캄파니 | Ｃｒｆ１ 수용체 길항제로서의 티아졸 피라졸로피리미딘 |
| CN103694242B (zh) * | 2013-12-10 | 2016-01-06 | 昆明翔昊科技有限公司 | 吡唑并嘧啶类化合物及其药物组合物和其在制药中的应用 |
| CN112479956A (zh) * | 2019-07-30 | 2021-03-12 | 杭州阿诺生物医药科技有限公司 | 一种用于制备腺苷受体抑制剂中间体的方法 |
| KR20240023691A (ko) | 2020-08-12 | 2024-02-22 | 스프루스 바이오사이언시스 인코포레이티드 | 다낭성 난소 증후군을 치료하기 위한 방법 및 조성물 |
| US11708372B2 (en) | 2021-11-19 | 2023-07-25 | Spruce Biosciences, Inc. | Crystalline composition of tildacerfont and methods of use and preparation thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3995039A (en) * | 1975-05-27 | 1976-11-30 | Merck & Co., Inc. | Pyrazolo [1,5-a] [1,3,5] triazines |
| JPS6157587A (ja) * | 1984-08-29 | 1986-03-24 | Shionogi & Co Ltd | 縮合複素環誘導体および抗潰瘍剤 |
| US4824834A (en) * | 1986-10-31 | 1989-04-25 | Otsuka Pharmaceutical Company, Limited | Pyrazolotriazine compounds |
| JP2691317B2 (ja) * | 1989-08-25 | 1997-12-17 | 株式会社大塚製薬工場 | ４―ヒドロキシ―８―（３―低級アルコキシ―４―フェニルスルフィニルフェニル）ピラゾロ〔１，５―ａ〕―１，３，５―トリアジン光学活性体の塩類及びその製造方法 |
| WO1992006096A1 (en) * | 1990-10-09 | 1992-04-16 | Otsuka Pharmaceutical Co., Ltd. | Pyrimidine derivative, production thereof, and androgen inhibitor |
| DK0591528T3 (da) * | 1991-04-22 | 1999-08-23 | Otsuka Pharma Co Ltd | Pyrazolo[1,5-a]pyrimidinderivat og antiinflammatorisk middel, der indeholder dette |
| US5356897A (en) * | 1991-09-09 | 1994-10-18 | Fujisawa Pharmaceutical Co., Ltd. | 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines |
-
1997
- 1997-07-23 JP JP50723398A patent/JP4704521B2/ja not_active Expired - Fee Related
- 1997-07-23 CA CA002259583A patent/CA2259583C/en not_active Expired - Lifetime
- 1997-07-23 NZ NZ333777A patent/NZ333777A/en not_active IP Right Cessation
- 1997-07-23 SK SK97-99A patent/SK286461B6/sk not_active IP Right Cessation
- 1997-07-23 EA EA199900158A patent/EA004403B1/ru not_active IP Right Cessation
- 1997-07-23 SI SI9720045A patent/SI9720045B/sl active Search and Examination
- 1997-07-23 EE EEP199900019A patent/EE04316B1/xx unknown
- 1997-07-23 CZ CZ0018499A patent/CZ299451B6/cs not_active IP Right Cessation
- 1997-07-23 IL IL12787197A patent/IL127871A0/xx unknown
- 1997-07-23 BR BR9710544A patent/BR9710544A/pt not_active IP Right Cessation
- 1997-07-23 PL PL97331523A patent/PL195762B1/pl unknown
- 1997-07-23 CN CN97196525A patent/CN1104432C/zh not_active Expired - Lifetime
- 1997-07-24 HR HRP970413 patent/HRP970413A2/hr not_active Application Discontinuation
-
1998
- 1998-12-30 IL IL127871A patent/IL127871A/en not_active IP Right Cessation
-
1999
- 1999-01-21 NO NO19990264A patent/NO315610B1/no not_active IP Right Cessation
-
2001
- 2001-05-30 CN CN 01120849 patent/CN1250223C/zh not_active Expired - Lifetime
-
2002
- 2002-04-25 CN CN 02118589 patent/CN1388126A/zh active Pending
- 2002-06-11 IL IL150163A patent/IL150163A/en not_active IP Right Cessation
-
2004
- 2004-07-23 JP JP2004216483A patent/JP4194539B2/ja not_active Expired - Fee Related
- 2004-10-12 IL IL164513A patent/IL164513A/en not_active IP Right Cessation
-
2005
- 2005-07-11 AR ARP050102868A patent/AR049583A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1225637A (zh) | 1999-08-11 |
| JP2005097257A (ja) | 2005-04-14 |
| SK286461B6 (sk) | 2008-10-07 |
| PL195762B1 (pl) | 2007-10-31 |
| NZ333777A (en) | 2000-07-28 |
| CZ299451B6 (cs) | 2008-07-30 |
| CN1327793A (zh) | 2001-12-26 |
| CN1388126A (zh) | 2003-01-01 |
| PL331523A1 (en) | 1999-07-19 |
| EA004403B1 (ru) | 2004-04-29 |
| CA2259583C (en) | 2009-11-17 |
| CN1250223C (zh) | 2006-04-12 |
| CN1104432C (zh) | 2003-04-02 |
| NO990264D0 (no) | 1999-01-21 |
| JP2002513382A (ja) | 2002-05-08 |
| AR049583A2 (es) | 2006-08-16 |
| NO315610B3 (no) | 2003-09-29 |
| SK9799A3 (sk) | 2005-04-01 |
| JP4704521B2 (ja) | 2011-06-15 |
| EE9900019A (et) | 1999-08-16 |
| IL127871A (en) | 2010-04-29 |
| CA2259583A1 (en) | 1998-01-29 |
| HRP970413A2 (en) | 1998-10-31 |
| CZ18499A3 (cs) | 1999-11-17 |
| EA199900158A1 (ru) | 1999-10-28 |
| NO990264L (no) | 1999-03-10 |
| JP4194539B2 (ja) | 2008-12-10 |
| IL127871A0 (en) | 1999-10-28 |
| IL164513A0 (en) | 2005-12-18 |
| SI9720045B (sl) | 2008-02-29 |
| IL150163A (en) | 2010-12-30 |
| IL164513A (en) | 2010-04-29 |
| BR9710544A (pt) | 1999-08-17 |
| NO315610B1 (no) | 2003-09-29 |
| SI9720045A (sl) | 1999-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE04282B1 (et) | Pürasoolpürimidiinid, nende valmistamine ja kasutamine ravimina ning neid sisaldav kompositsioon | |
| EE200400059A (et) | Diarüültsükloalküülderivaadid, nende kasutamine ravimite valmistamiseks ning neid sisaldav ravim | |
| EE04354B1 (et) | Indolüül-3-glüoksüülhappe derivaadid, nende kasutamine ravimite valmistamiseks ja neid sisaldavad kasvajavastase toimega ravimid | |
| EE04965B1 (et) | Imidasoimidasoolid ja triasoolid kui p?letikuvastased hendid, nende kasutamine ravimite valmistamiseks ning farmatseutiline kompositsioon | |
| ID22565A (id) | Penggunaan nanodispersi dalam formulasi akhir obat | |
| DE69928260D1 (de) | Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen | |
| DE69618587T2 (de) | Chinazoline und pharmazeutische zusammensetzungen | |
| MA26553A1 (fr) | Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la | |
| DE69822209D1 (de) | ESTRON-SULFatase HEMMENDE ESTRON-SULFAMATVERBINDUNGEN, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON | |
| LV12624A (lv) | Thienylazolylalcoxyethanamines their preparation and their application as medicaments | |
| HUP0103884A3 (en) | Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use | |
| EE04151B1 (et) | Atsüülpiperasinüülpürimidiinide derivaadid, nendevalmistamine ja kasutamine ravimitena | |
| ATE240315T1 (de) | Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate | |
| DE69830119D1 (de) | Teigzusammensetzung und derer Herstellung | |
| EE200200271A (et) | Ravimkombinatsioonid ning nende kasutamine | |
| HUP9802132A3 (en) | Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them | |
| EE04316B1 (et) | Asolotriasiinid ja -pürimidiinid, neid sisaldavadfarmatseutilised kompositsioonid ning nende kasutamine ravimite valmistamiseks | |
| HUP0104852A3 (en) | Oktahydro-pyrido-pyrazine derivatives and pharmaceutical compositions containing the same and their use | |
| EE9900034A (et) | Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine | |
| BR0012184B1 (pt) | compostos derivados de indol, formulação farmacêutica, e, composição e uso dos compostos na fabricação de medicamentos | |
| DE69312319T2 (de) | Tachyquinin antagonisten, ihre herstellung und ihre verwendung in pharmazeutischen formulierungen | |
| NO20001717D0 (no) | Serotonin-inneholdende formulering for oral administrering og anvendelse av samme | |
| HUP0104834A3 (en) | Sulphonyloxazolamines, their use, pharmaceutical compositions containing them and their preparation | |
| EE9700230A (et) | Bitsüklilised tahhükiniini antagonistid, nende valmistamine ja kasutamine ravimsegus | |
| NO20014692D0 (no) | 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20041231 |
|
| LD4A | Amendment in the specification | ||
| KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20101231 |